North America consists of three major countries, namely the US, Canada, Mexico. The US is the largest market for skin grafts, followed by Canada and Mexico. In North America, the US is the largest market for a skin graft. The market's growth is driven by increasing surgical procedures of skin grafting, high prevalence of skin cancer, and growing developments by the companies operating in the market. In the US, skin cancer is the most common type of cancer. As per the America Academy of Dermatology, one in five Americans is likely to develop skin cancer in their lifetime, and nearly 9,500 people are diagnosed with skin cancer. Furthermore, basal cell carcinoma and squamous cell carcinoma affect more than 3 million Americans per year. The Center for Disease Control (CDC) stated that more than 1.1 million people suffer burn injuries that need medical care every year in the US. Furthermore, nearly 50,000 burn victims require hospitalization, and 20,000 suffer major burns covering 25% of their body surface. It also stated that in the US, 10,000 peopled, i.e., each year, due to burn-related infections. Thus, owing to the increasing incidences of skin cancer, and surgical procedures for skin graft are likely to propel the market's growth. Moreover, the growing developments in the field of skin graft by companies and research organizations are contributing to the market's growth by innovating technologies and products. For instance, Mallinckrodt Pharmaceuticals has developed an artificial skin tissue named Stragraft. The product is under clinical trials; in phase III clinical trial, it has shown positive results for 81% of second-degree burn wounds. In August 2020, the US FDA accepted Stratatech Biologics License Application (BLA) from Mallinckrodt Pharmaceuticals for StrataGraft. Such instances of product developments are likely to influence the growth of the market during the forecast period
The outbreak of the COVID-19 pandemic has adversely affected the non-healing or chronic wound management and regenerative medicine market. Various people across the North American region are affected. For instance, the US is a highly affected country in the North American regions. The effect of the corona is mild in adults; however, it is adverse in older people. The infection of corona among older people has resulted in severe complications and has accounted for a higher number of deaths in the country. In addition, skin cancer is majorly seen in older people in US and 1 in 5 Americans will develop skin cancer by the age of 70. More than 2 people die of skin cancer in the U.S. every hour. Therefore, regular dressing and proper care is required to prevent chronic cases of infection and health condition. Due to the outbreak of COVID-19, various hospitals were engaged in treating the affected people. Additionally, various wound care centers are located in hospitals. Hence, majority of the patients did not receive wound care. ~ 1 in 4 patients is able to receive wound care, and it is expected that there are nearly 6.7 million people across the US those are waiting for the wound treatment. Researchers evaluated the stability of SARS-CoV-2 and influenza A virus (IAV), mixed with culture medium or upper respiratory mucus, on human skin surfaces, and the dermal disinfection effectiveness of 80 per cent (w/w) ethanol against SARS-CoV-2 and IAV. Researchers conducted lab experiments using cadaver skin that would otherwise have been used for skin grafts to avoid possibly infecting healthy volunteers. The outbreak of COVID-19 has impact skin graft market profoundly by affecting the quality care.
Strategic insights for the North America Skin Graft provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 426.44 Million |
Market Size by 2028 | US$ 664.40 Million |
Global CAGR (2021 - 2028) | 6.5% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Product
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
The geographic scope of the North America Skin Graft refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The skin graft market in North America is expected to grow from US$ 426.44 million in 2021 to US$ 664.40 million by 2028; it is estimated to grow at a CAGR of 6.5% from 2021 to 2028. Research activities and product innovations; skin grafts are a major requirement in the wound care industry. However, the availability of a suitable donor is a major concern in skin grafting market. Hence, over the years, researchers have been carrying out R&D activities which have resulted in product innovations. There are several products in the clinical trial phase, which can boost the market of skin grafts in the coming years. In June 2017, Mallinckrodt plc enrolled the first patient in phase 3 trial of StrataGraft regenerative skin tissue. The research activities as well as product innovations are expected to provide impetus for the growth of the skin graft market in the coming years.
Based on product, the market is segmented into autologous, allogeneic, xenogeneic, prosthetic, and isogeneic. In 2020, the autologous segment held the largest share of the market. Based on graft thickness, the market is divided into split-thickness, full-thickness and composite graft. In 2020, the split thickness segment held the largest share of the market. Based on equipment, the market is segmented into dermatome, general surgical instruments, consumables, and others
A few major primary and secondary sources referred to for preparing this report on the skin graft market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are AVITA Medical
The North America Skin Graft Market is valued at US$ 426.44 Million in 2021, it is projected to reach US$ 664.40 Million by 2028.
As per our report North America Skin Graft Market, the market size is valued at US$ 426.44 Million in 2021, projecting it to reach US$ 664.40 Million by 2028. This translates to a CAGR of approximately 6.5% during the forecast period.
The North America Skin Graft Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Skin Graft Market report:
The North America Skin Graft Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Skin Graft Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Skin Graft Market value chain can benefit from the information contained in a comprehensive market report.